Nadia Falzone
Research Subjects
Nadia Falzone has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alain Batalla
Medical Physics Department, CLCC François Baclesse, 14000 Caen, France
1 shared publication - Aurélien Corroyer-Dulmont
Medical physics department, Centre François Baclesse, Caen, France
1 shared publication - Cindy Bertaut
Medical Physics Department, Cherbourg Hospital, 50100 Cherbourg, France
1 shared publication - Cyril Jaudet
Medical Physics Department, Centre François Baclesse, 14000 Caen, France
1 shared publication - E.M. Abbott
MIM Software Inc., Cleveland, Ohio, USA
1 shared publication - Katherine Anne Vallis
Department of Oncology, University of Oxford, Oxford, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 2 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (5) , 943
Deep Hybrid Learning Prediction of Patient-Specific Quality Assurance in Radiotherapy: Implementation in Clinical Routine
Background: Arc therapy allows for better dose deposition conformation, but the radiotherapy plans (RT plans) are more complex, requiring patient-specific pre-treatment quality assurance (QA). In turn, pre-treatment QA adds to the workload. The objective of this study was to develop a predictive model of Delta4-QA results based on RT-plan complexity indices to reduce QA workload. Methods. Six complexity indices were extracted from 1632 RT VMAT plans. A machine learning (ML) model was developed for classification purpose (two classes: compliance with the QA plan or not). For more complex locations (breast, pelvis and head and neck), innovative deep hybrid learning (DHL) was trained to achieve better performance. Results. For not complex RT plans (with brain and thorax tumor locations), the ML model achieved 100% specificity and 98.9% sensitivity. However, for more complex RT plans, specificity falls to 87%. For these complex RT plans, an innovative QA classification method using DHL was developed and achieved a sensitivity of 100% and a specificity of 97.72%. Conclusions. The ML and DHL models predicted QA results with a high degree of accuracy. Our predictive QA online platform is offering substantial time savings in terms of accelerator occupancy and working time.
- 2 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (5) , 943
Open AccessDeep Hybrid Learning Prediction of Patient-Specific Quality Assurance in Radiotherapy: Implementation in Clinical Routine
Background: Arc therapy allows for better dose deposition conformation, but the radiotherapy plans (RT plans) are more complex, requiring patient-specific pre-treatment quality assurance (QA). In turn, pre-treatment QA adds to the workload. The objective of this study was to develop a predictive model of Delta4-QA results based on RT-plan complexity indices to reduce QA workload. Methods. Six complexity indices were extracted from 1632 RT VMAT plans. A machine learning (ML) model was developed for classification purpose (two classes: compliance with the QA plan or not). For more complex locations (breast, pelvis and head and neck), innovative deep hybrid learning (DHL) was trained to achieve better performance. Results. For not complex RT plans (with brain and thorax tumor locations), the ML model achieved 100% specificity and 98.9% sensitivity. However, for more complex RT plans, specificity falls to 87%. For these complex RT plans, an innovative QA classification method using DHL was developed and achieved a sensitivity of 100% and a specificity of 97.72%. Conclusions. The ML and DHL models predicted QA results with a high degree of accuracy. Our predictive QA online platform is offering substantial time savings in terms of accelerator occupancy and working time.
- 1 November 2021
- Published by Elsevier in Clinical Oncology
- Vol. 33 (11) , 735-743
Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks
- 1 November 2021
- Published by Elsevier in Clinical Oncology
- Vol. 33 (11) , 735-743
Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks